•  
  •  
  •  
  •  

2025-10-08 02:14:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  FDC

Stock Report

  • FDC Ltd receives USFDA approval for ANDA Pilocarpine Hydrochloride Ophthalmic Solutions
  • FDC Ltd Q1FY26 consolidated net profit up at Rs. 121.35 crores
  • FDC Ltd to expand Liquid Oral facility at Sinnar Plant
  • FDC Ltd receives final approval from USFDA for ANDA Cefixime 400 mg Tablets
  • FDC Ltd consolidated Q2FY25 PAT slides QoQ to Rs. 72.04 crores
  • FDC Ltd successfully completes USFDA inspection at Baddi manufacturing facility
  • FDC Ltd's Q1 FY24 consolidated net profit surges to Rs. 109.88 crores
  • FDC Ltd receives EIR from USFDA for Manufacturing Facility at Waluj
  • FDC Ltd consolidated Q4 FY2023 net profit drops QoQ to Rs. 30.71 crores
  • Kings Infra Ventures signs agreement with Karnataka Fisheries Development Corporation
  • FDC announces successful completion of USFDA audit of API unit at Roha, Raigad
  • FDC Ltd successfully completes USFDA inspection at Sterile facility, Waluj
  • FDC Ltd consolidated Q3 FY2023 net profit slips QoQ to Rs. 40.74 crores
  • FDC Limited's Brand ZIFI and FAVENZA awarded at AWACS 2022
  • FDC Ltd consolidated Q1FY23 profit jumps QoQ to Rs. 70.73 crores
  • FDC Ltd consolidated Q4 FY2022 net profit slides to Rs. 10.44 crores
  • FDC Ltd board approves buyback proposal
  • FDC Ltd consolidated Q3FY22 net profit at Rs. 35.6923 crores
  • FDC Ltd gets GMP certificate from PICs-NPRA, Malaysia
  • FDC Limited received ANDA approval for Ofloxacin Otic Solution, 0.3%
  • FDC Limited posts consolidated Q2FY22 PAT of Rs. 72.39 crore

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024